logo
episode-header-image
Oct 2022
1h 18m

#361 Advanced Lipidology

The Curbsiders Internal Medicine Podcast
About this episode
Lipids Update 2022: Cardiovascular Risk Reduction and New Medications on the Horizon with Erin Michos, MD

Show description: 
Ready to take the next step in management of your patient with hyperlipidemia? Dr. Erin Michos (@erinmichos) returns to give us a lesson in Advanced Lipidology. She updates us on what new medications we can use for those difficult to treat lipids and what medications are on the horizon.

Unfortunately, this episode will not be available for CME. You can claim free CME for other episodes at curbsiders.vcuhealth.org!

Episodes | Subscribe | Spotify | Swag! | Top Picks | Mailing List | askcurbsiders@gmail.com | Free CME!

Show Segments

  • Intro, Getting to know Dr. Erin Michos, Pick of the Week
  • Patient Case, Digging into ASCVD Risk 
  • Coronary artery calcium scoring - why it’s important
  • What are “Risk Enhancing Factors”?
  • Biomarker testing, what is the significance of Lip a and how can we use it to drive management?
  • Introduction to PCSK9 inhibitors
  • More than just statins - other LDL-lowering medications
  • siRNAs, ASOs - Pelacarsen and more
  • Apollo Trial regarding Pelacarsen
  • Importance of Family History
  • What to do if maxed out on a statin or statin intolerance - Ezetimibe, PCSK9 inhibitors, MAB therapies, and more
  • Bempedoic Acid discussion
  • Medication side effects
  • Homozygous FH - approach to treatment, ANGPTL3 inhibitors
  • Triglycerides discussion, icosapent ethyl, the REDUCE-IT trial
  • Wrap-up and Take home points, Outtro
Credits

  • Producer and written by: Christopher Chiu MD, FACP, FAAP
  • Show Notes: James Antaki MD
  • Infographic: Edison Jyang
  • Cover Art: Kate Grant MBChB, DipGUMed
  • Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP   
  • Associate Editor: Leah Witt MD
  • Showrunner: Matthew Watto MD, FACP
  • Technical Production: PodPaste
  • Guest: Erin Michos MD, MHS

Sponsor:
Birch Living

Birch is giving $400 off all mattresses and 2 free eco-rest pillows at BirchLiving.com/curb

Full transcript HERE
Up next
Jul 7
490: Update! Anticoagulation for Venous Thromboembolism with Dr. Tara Lech, PharmD
Master the latest approaches for treating venous thromboembolism with expert tips on direct oral anticoagulant (DOAC) selection, dosing, and duration. Learn how to tailor anticoagulation for special populations, handle treatment failures, and navigate long-distance travel risks. ... Show More
1h 24m
Jun 30
#489 Live from SHM #Converge2025 Rheumatology for the Hospitalist
Take the ache out of those joint aches! Learn about inpatient diagnosis and management of crystalline arthropathies as well as a brief conversation about those rheumatology NOS cases. We’re joined by Dr. Kimberly Trotter, MD (University of Chicago). Claim CME for this episode at ... Show More
47m 14s
Jun 23
#488 DIGEST: Cytisinicline for smoking cessation, partner treatment for BV, combination therapy with statins and ezetimibe, and exercise and survival in colon cancer
Join us as we review recent practice-changing articles on the effect of combination statin and ezetimibe in reducing myalgias, male partner treatment for BV, semaglutide for MASH/liver fibrosis, exercise and cancer risk, and cytisinicline for smoking cessation. Fill your brain ho ... Show More
1h 3m
Recommended Episodes
Jun 2023
Decoding Hyperlipidemia Management: What Does the Evidence Say? - Frankly Speaking Ep 332
Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-332 Overview: In this episode, we take a look at the dynamic landscape of hyperlipidemia management, discussing current guidelines ... Show More
12m 58s
Jan 2024
#326: Ozempic and Other Semaglutide Medications
Semaglutide, which is sold under the brand names Ozempic, Wegovy and Rybelsus, has become increasingly popular and is a medication you are likely to encounter in the clinical setting and when reviewing your patient’s medical histories. In this article, you’ll learn the key things ... Show More
17m 37s
Jun 2024
What’s Inside Your Coronary Arteries? with Anita Vadria, MS, PA-C (Episode 182)
Menopause and age raise our cardiovascular disease risk. Athletes and highly active people also tend to have a higher prevalence of coronary artery calcium and atherosclerotic plaque (though it tends to be the benign kind). But what does that all mean? How can we know what’s real ... Show More
45m 31s
Jun 2024
Jun 14 2024 This Week in Cardiology
Listener feedback, statin eligibility and Yogi Berra, evidence-based medicine and heterogenous treatment effects, and MRAs in HF are the topics John Mandrola, MD, discusses in this week’s podcast. This podcast is intended for healthcare professionals only. To read a partial trans ... Show More
30m 52s
Mar 2018
NSAID Pharmacology RLP Episode 008
In this podcast episode I discuss the pharmacology of NSAIDs and the potential collateral damage that can result from these medications.  We’ll cover: Side effects Mechanism of Action Important Drug Interactions Pharmacokinetics between ibuprofen and naproxen Boxed Warnings Hope ... Show More
11m 42s
Apr 2024
Episode 69:DUPLEX Sparsentan, it’s no Acthar Gel
The Filtrate:Joel TopfSwapnil HiremathPriya Yenebere Nayan AroraWith Special Guest:Brendon Neuen Super smart guy and clinical trialistMichelle Rheault Lead author of DUPLEX and friend of the podShow NotesSparsentan versus Irbesartan in Focal Segmental GlomerulosclerosisNephJC Sum ... Show More
1h 41m
May 2024
ACE Inhibitors: Maybe Not for Hypertension Alone - Frankly Speaking Ep 380
Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-380 Overview: This episode brings you a comparison of thiazide diuretics, angiotensin-converting enzyme (ACE) inhibitors, and calc ... Show More
9m 1s
Dec 2023
36. Does tranexamic acid increase the risk of thromboembolism?
Dr. Zach Cost and Dr. Tem Bendapudi join the show to discuss the literature pertaining to tranexamic acid and thromboembolic risk. Dr. Zach Cost is an anesthesia resident at the Massachusetts General Hospital. Dr. Pavan (“Tem”) Bendapudi holds a joint faculty appointment in the D ... Show More
1 h
Jan 2024
Fenofibrate Pharmacology Podcast Episode 310
On this podcast episode, I discuss fenofibrate pharmacology, adverse effects, kinetics, drug interactions, and much more! Fenofibrate is typically only used for hypertriglyceridemia. The primary risk of hypertriglyceridemia is pancreatitis so we treat these levels because of this ... Show More
13m 17s
Apr 2019
Chapter 30: Pharmacology
Content covered in this episode includes: [0:29] Question Dissection: A 31-year-old woman is brought to the E.D. by friends at 3 A.M. after they were unable to wake her up... [4:29]Pharmacology chapter of S2S including questions like: - What two developments in NSAID therapy may ... Show More
24m 6s